Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Allsop

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
Nanomedicine : Nanotechnology, Biology, and Medicine|July 5, 2011
Effect of curcumin-associated and lipid ligand-functionalized nanoliposomes on aggregation of the Alzheimer's Aβ peptideMark Taylor, Susan Moore, Spyridon Mourtas, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 8, 2016
Magnetite pollution nanoparticles in the human brainBarbara A Maher, Imad A M Ahmed, Vassil Karloukovski, et al.
The Analyst|September 6, 2018
Blood-based near-infrared spectroscopy for the rapid low-cost detection of Alzheimer's diseaseMaria Paraskevaidi, Camilo L M Morais, Daniel L D Freitas, et al.
FEBS Letters|July 10, 2007
Copper-mediated formation of hydrogen peroxide from the amylin peptide: a novel mechanism for degeneration of islet cells in type-2 diabetes mellitus?Atef Masad, Lee Hayes, Brian J Tabner, et al.
Plos One|November 29, 2021
Amyotrophic lateral sclerosis: Correlations between fluid biomarkers of NfL, TDP-43, and tau, and clinical characteristicsYuta Kojima, Takashi Kasai, Yu-Ichi Noto, et al.
Plos One|December 1, 2017
Increased levels of plasma total tau in adult Down syndromeTakashi Kasai, Harutsugu Tatebe, Masaki Kondo, et al.
Brain : a Journal of Neurology|January 22, 2009
Detection of elevated levels of soluble alpha-synuclein oligomers in post-mortem brain extracts from patients with dementia with Lewy bodiesKaterina E Paleologou, Christine L Kragh, David M A Mann, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 3, 2024
A novel peptide-based tau aggregation inhibitor as a potential therapeutic for Alzheimer's disease and other tauopathiesAnthony Aggidis, George Devitt, Yongrui Zhang, et al.
Journal of Medicinal Chemistry|January 21, 2016
Designed Glycopeptidomimetics Disrupt Protein-Protein Interactions Mediating Amyloid β-Peptide Aggregation and Restore Neuroblastoma Cell ViabilityJulia Kaffy, Dimitri Brinet, Jean-Louis Soulier, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 7, 2017
Differential diagnosis of Alzheimer's disease using spectrochemical analysis of bloodMaria Paraskevaidi, Camilo L M Morais, Kássio M G Lima, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Nanomedicine : Nanotechnology, Biology, and Medicine|July 5, 2011
Effect of curcumin-associated and lipid ligand-functionalized nanoliposomes on aggregation of the Alzheimer's Aβ peptideMark Taylor, Susan Moore, Spyridon Mourtas, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 8, 2016
Magnetite pollution nanoparticles in the human brainBarbara A Maher, Imad A M Ahmed, Vassil Karloukovski, et al.
The Analyst|September 6, 2018
Blood-based near-infrared spectroscopy for the rapid low-cost detection of Alzheimer's diseaseMaria Paraskevaidi, Camilo L M Morais, Daniel L D Freitas, et al.
FEBS Letters|July 10, 2007
Copper-mediated formation of hydrogen peroxide from the amylin peptide: a novel mechanism for degeneration of islet cells in type-2 diabetes mellitus?Atef Masad, Lee Hayes, Brian J Tabner, et al.
Plos One|November 29, 2021
Amyotrophic lateral sclerosis: Correlations between fluid biomarkers of NfL, TDP-43, and tau, and clinical characteristicsYuta Kojima, Takashi Kasai, Yu-Ichi Noto, et al.
Plos One|December 1, 2017
Increased levels of plasma total tau in adult Down syndromeTakashi Kasai, Harutsugu Tatebe, Masaki Kondo, et al.
Brain : a Journal of Neurology|January 22, 2009
Detection of elevated levels of soluble alpha-synuclein oligomers in post-mortem brain extracts from patients with dementia with Lewy bodiesKaterina E Paleologou, Christine L Kragh, David M A Mann, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 3, 2024
A novel peptide-based tau aggregation inhibitor as a potential therapeutic for Alzheimer's disease and other tauopathiesAnthony Aggidis, George Devitt, Yongrui Zhang, et al.
Journal of Medicinal Chemistry|January 21, 2016
Designed Glycopeptidomimetics Disrupt Protein-Protein Interactions Mediating Amyloid β-Peptide Aggregation and Restore Neuroblastoma Cell ViabilityJulia Kaffy, Dimitri Brinet, Jean-Louis Soulier, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 7, 2017
Differential diagnosis of Alzheimer's disease using spectrochemical analysis of bloodMaria Paraskevaidi, Camilo L M Morais, Kássio M G Lima, et al.
Pageof 7